#IBAI summarise how the GaM phase I trial data could be used and estimate value?
lse.co.uk/profiles/howdl…
English
Philip Howdle
7.5K posts
Philip Howdle
@howdlep
UK Small Cap Trader of #IBAI (formerly #IQAI) and a lifelong supporter of @AVFCOfficial. Views my own, please DYOR.
Taunton Katılım Ekim 2009
437 Takip Edilen1.4K Takipçiler
#IBAI what are the benefits of yesterday's award of a new $3m NIH grant to the Medical College of Wisconsin & a sub award to IBAI, in relation 2 the likelihood of another company advancing the completed phase I GaM trial into a new phase II trial?
lse.co.uk/profiles/howdl…
English
#IBAI this is excellent news but surely this should be the subject of an RNS.
Never miss the opportunity to promote our story to a wider audience!
Imaging Biometrics@ImgBiometrics
Congratulations to Dr. Mona Al‑Gizawiy of the Medical College of Wisconsin on securing a new NIH R01 award—and to announce our role as a sub‑award recipient on this important project. This five‑year, $3M grant will accelerate the understanding of gallium maltolate (GaM), a promising oral therapy targeting some of the most aggressive pediatric brain cancers. Under Dr. Al‑Gizawiy’s leadership, the pre-clinical project will advance the combination of GaM with radiation therapy, building on early evidence that GaM can enhance treatment effectiveness. IB will support this work with our FDA‑cleared quantitative MR imaging platform—including our advanced Fractional Tumor Burden (FTB) maps—which delivers standardized, highly sensitive measures of tumor response. This capability is essential for evaluating emerging therapies and represents a key differentiator in the neuro‑oncology imaging market. “IB’s quantitative imaging gives us an early and reliable window into how tumors respond to treatment—something conventional scans simply can’t match,” said Dr. Al‑Gizawiy. IB packages pre-clinical imaging workflows to create a unified imaging ecosystem that strengthens our position across research and clinical markets. This initiative supports long‑term growth by expanding IB’s footprint in translational research and multi‑site trials. #PediatricBrainCancer #ChildhoodCancerResearch #PediatricOncology #BrainTumorResearch #DIPG #Glioblastoma #ATRT #HighGradeGlioma #ftbmaps
English
Imaging Biometrics@ImgBiometrics
Watch the recent IB User's Group Webinar featuring IB Nimble 2: youtu.be/jPcQviLb6fc?si… IB Nimble turns complex care coordination into a high‑velocity, encrypted data stream—connecting multidisciplinary teams in real time. Faster consults, tighter workflows, optimal care delivery —this is multidisciplinary medicine without the bottlenecks... it’s the future of multidisciplinary decision‑making in the palm of your hand. #radiologyworkflow #mobilehealth #HIPAACompliant
QHT
#IBAI little tick up on the offer, L2 now firmed. Time for a run if volume picks up a bit.
English
#IBAI with thanks to Musella Foundation supporting the Extended Access Program (EAP) despite IBAI not going ahead with Phase II of GaM. So is real world data being prepared for a new partner sponsoring Phase II or will the data, owned by IBAI, be sold?
tinyurl.com/5h9vrfma
English
#IBAI application to GaM met by:-
Defined Target (tumour metabolism & iron dependant cancer growth)
Disease Context (Glioblastoma is an aggressive cancer with poor diagnosis)
Mechanism driven (GaM reduces tumour size by blocking iron uptake)
English
#IBAI @ImgBiometrics with the Pediatric Disease Priority Review Voucher now reauthorised & the Mikaela Naylon Give Kids a Chance Act passed into law night, will this now incentivise Phase II of the GaM trial? Either way the data from Phase I has just got a whole lot more valuable
English
#IBAI IB Nimble - Group Webinar 27/2/26 at 6.30pm
Discover how IB Nimble empowers oncology teams with smart diagnostic algorithms, seamless expert collaboration, and faster clinical decision-making.
@ba3144f9-19be-48de-a24b-d30d716b86ad" target="_blank" rel="nofollow noopener">events.teams.microsoft.com/event/17631bab…
English
#IBAI Additionally have partnered with Blackford Analysis ltd 2sell their products 2a growing global client base, which can streamline the integration & employment of advanced AI technology. This collaboration supports the use of mobile technology across the healthcare enterprise
English
#IBAI IB Delta T1 maps are FDA approved, patent pending. FTB maps are FDA approved based on IB Neuro FDA approval.
Already part of the expanded distribution agreement with GE Healthcare
ibailtd.com/2025/12/rns-01…
Imaging Biometrics@ImgBiometrics
A comparative analysis between normalized rCBV, and @ImgBiometrics standardized rCBV (IB Neuro), and FTB (IB Delta T1 Maps & IB Neuro) - and why the choice matters for brain tumor imaging. Contact IB for more information including references. @TheASNR @AlMusella @theABTA @NBTStweets
English
#IBAI so could the Give Kids a Chance Act, the extension of the Rare Pediatric Disease Priority Review Vouchers, the Extended Access Program & the Plausible Mechanism Pathway make a Phase II trial unnecessary?
NB IBAI are not proceeding with PII due to cost, but own the PI data.
English
#IBAI On Friday Zak noted the rising trend channel base, uptrend line in the RSI window which is looking good. Recent resistance broken at 0.55p. Now target top of the channel as high as 0.87p. Cautious may wait for EOD close > 0.67p. RSI passed > 50, so rally likely to have legs
Zaks Traders Cafe@ZaksTradersCafe
Bulletin Board Heroes: February 20 Zak Mir takes a charting look at FTSE 100, Dax, Dow, Bitcoin, Ethereum, Gold, Aferian, Delta Gold, Fulcrum, Helium One, Imaging Biometrics, Jangada, Jersey, Inspecs, Serval, Sintana, Tullow, Thruvision, United Oil & Gas, WeCap, Warpaint. - Zaks Traders Cafe zakstraderscafe.com/bulletin-board… #FTSE100 #DAX #DOW #BTC #ETH #Gold #AFRN #DGQ #FMET #HE1 #IBAI #JAN #JOG #SPEC #SRVL #SEI #TLW #THRU #UOG #WCAP #W7L
English
#IBAI it's been a while since we last saw premium buys. I wonder if the new director is buying in?
Philip Howdle@howdlep
#IBAI we have buys and L2 is moving. Can't even get a quote to buy 150k shares
English
#IBAI we have buys and L2 is moving. Can't even get a quote to buy 150k shares
English
@ImgBiometrics #IBAI @grok Discuss the Imaging Biometrics (@ImgBiometrics ) and QSM Metric business partnership, including comment on future development and how the enhanced partnership with GE HealthCare will accelerate access to this technology.
English
Even the most advanced adaptive stimulation depends on one fundamental truth:
🎯 You still have to hit the right target.
That’s where QSM Metric® comes in.
#DBS #Neurosurgery #MovementDisorders #Neuromodulation #QSM
English
#IBAI a comprehensive update. A small profit for the year and no need for a placing, which is excellent.
Update and IB Nimble Webinar – 27 February 2026 | Company Announcement | Investegate
investegate.co.uk/announcement/r…
English